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ABSTRACT
Poly(ADP-ribose) polymerase-1-dependent cell death
(known as parthanatos) plays a pivotal role in many
clinically important events including ischaemia/reperfusion
injury and glutamate excitotoxicity. A recent study by us
has shown that uncleaved AIF (apoptosis-inducing factor),
but not calpain-hydrolysed truncated-AIF, was rapidly
released from the mitochondria during parthanatos,
implicating a second pool of AIF that might be present in
brain mitochondria contributing to the rapid release. In the
present study, a novel AIF pool is revealed in brain
mitochondria by multiple biochemical analyses. Approx.
30% of AIF loosely associates with the outer mitochondrial
membrane on the cytosolic side, in addition to its main
localization in the mitochondrial intermembrane space
attached to the inner membrane. Immunogold electron
microscopic analysis of mouse brain further supports AIF
association with the outer, as well as the inner,
mitochondrial membrane in vivo. In line with these
observations, approx. 20% of uncleaved AIF rapidly
translocates to the nucleus and functionally causes
neuronal death upon NMDA (N-methyl-D-aspartate) treat-
ment. In the present study we show for the first time a
second pool of AIF in brain mitochondria and demonstrate
that this pool does not require cleavage and that it
contributes to the rapid release of AIF. Moreover, these
results suggest that this outer mitochondrial pool of AIF is
sufficient to cause cell death during parthanatos.
Interfering with the release of this outer mitochondrial
pool of AIF during cell injury paradigms that use
parthanatos hold particular promise for novel therapies
to treat neurological disorders.
Key words: apoptosis-inducing factor (AIF), immunogold
electron microscopy, mitochondrion, parthanatos,
poly(ADP-ribose) polymerase-1.
INTRODUCTION
Mitochondria play a critical role in cell death via regulating
the release of pro-apoptotic proteins including cyt c
(cytochrome c) and AIF (apoptosis-inducing factor)
(Martinou and Green, 2001). AIF was initially thought to be
located in the intermembrane space of mitochondria in a
57 kDa soluble form (Susin et al., 1999). However, Otera et al.
(2005) showed that mature AIF, which contains a hydro-
phobic transmembrane segment, is a 62 kDa type-I inner
membrane protein with the N-terminus exposed to the
matrix and the C-terminal portion exposed to the inter-
membrane space. To be released from the mitochondria, AIF
would then need to be processed into a 57 kDa soluble form
by removing the hydrophobic transmembrane segment.
AIF is a critical mediator for PARP-1 [poly(ADP-ribose)
polymerase-1]-initiated cell death (known as parthanatos).
PARP-1 is a nuclear enzyme which acts as a DNA damage
sensor (Lautier et al., 1993; de Murcia et al., 1994; Shall and
de Murcia, 2000). PARP-1 overactivation mediates cell death
under different pathological conditions, including ischaemia/
reperfusion injury (Eliasson et al., 1997; Pieper et al., 2000),
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Abbreviations: AIF, apoptosis-inducing factor; ANT, adenine nucleotide translocator; cyt c, cytochrome c; Hq, Harlequin; MnSOD, manganese superoxide dismutase; NMDA,
N-methyl-D-aspartate; PARP-1, poly(ADP-ribose) polymerase-1; ROI, region of interest; Smac, second mitochondrial-derived activator of caspase; Tim23, translocase of inner
membrane 23; Tom20, translocase of outer membrane 20; VDAC, voltage-dependent anion channel; WT, wild-type.
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asnneuro.org / Volume 1 (5) / art:e00021 275glutamate excitotoxicity (Mandir et al., 2000; Yu et al., 2002;
Wang et al., 2004), oxidative stress, inflammation (Szabo and
Dawson, 1998) and in models of Parkinson’s disease (Cosi and
Marien, 1999; Mandir et al. 1999). In parthanatos, the key
event is AIF release from the mitochondria and translocation
to the nucleus, followed by chromatin condensation, large-
scale DNA fragmentation and subsequent cell death (Wang et
al. 2009a). Calpain, a calcium-dependent intracellular
cysteine protease, has been suggested to play an important
role in mitochondrial AIF release under certain cell-death
pathways via hydrolysing mature AIF to 57 kDa truncated AIF
(Polster et al., 2005; Cao et al. 2007; Moubarak et al. 2007).
However, a recent study by us has shown that it is the 62 kDa
uncleaved mature AIF that is released from the mitochondria
to the nucleus, and calpain was not required for mitochon-
drial AIF release in parthanatos (Wang et al. 2009b).
Inhibition of calpain with calpastatin or genetic knockout
of the regulatory subunit of calpain failed to prevent NMDA
(N-methyl-D-aspartate)- or MNNG (N-methyl-N9-nitro-N-
nitrosoguanidine)-induced AIF nuclear translocation and
subsequent cell death. In line with our observation, another
group has also shown that mitochondrial m-calpain is not
involved in the processing of AIF (Joshi et al. 2009).
Additionally, AIF release is detected before cyt c in
parthanatos in spite of its larger molecular mass, 57–67
kDa compared with 14 kDa respectively (Yu et al., 2002, 2003;
Wang et al., 2004). Taken together, these observations
suggest that a second pool of AIF might exist in brain
mitochondria which contributes to the rapid release as the
uncleaved form during parthanatos.
In the present paper we report that endogenous AIF has
two major submitochondrial localizations in brain. One is at
the outer mitochondrial membrane on the cytosolic side, and
the other localization is in the intermembrane space,
attached to the inner membrane. There is little detectable
free, soluble AIF in the intermembrane space. The present
finding of two pools of mitochondrial AIF expand the current
concept of mitochondrial AIF, and may provide a better
understanding of AIF release under different cell-death
paradigms.
MATERIALS AND METHODS
Preparation and treatment of mitochondria from
brain
All animal experiments were approved by the Animal Care
and Use Committee at the John Hopkins University School of
Medicine. Non-synaptosomal mitochondria were prepared
from adult mouse or rat brains (6–8 weeks of age) using the
Percoll gradient method as described previously (Kristian and
Fiskum, 2004). Respiration of mitochondrial preparations
were evaluated with a Clark-type oxygen electrode (Polster
et al., 2001). The final mitochondria stock was prepared in
isotonic buffer [300 mM sucrose and 10 mM Hepes (pH 7.4),
without EGTA]. Rat brain was used for submitochondrial
fractionation experiments using a French press (Thermo). For
the alkaline treatment, mitochondrial pellets were resus-
pended in 0.1 M Na2CO3 (pH 11.5) and incubated on ice for
20 min. The soluble supernatant and insoluble membrane frac-
tions were separated by ultracentrifugation [37000 rev./min
(TLA-120.2 rotor) for 30 min]. For salting-out experiments, the
mitochondrial fraction (3 mg/ml) was divided into several
aliquots, centrifuged at 12000 g for 5 min, and the pellets
were resuspended in the salting-out buffer [250 mM sucrose,
25 mM KCl, 5 mM MgCl2, 0.1 mM PMSF, 10 mM Tris/HCl
(pH 7.4) and protease inhibitors (Roche) containing different
concentrations of NaCl]. For the proteinase K treatment, the
mitochondria were prepared without protease inhibitor and
were incubated with 1 mg of proteinase K at 37˚C. The
antibodies against AIF and MnSOD (manganese superoxide
dismutase) have been described previously (Yu et al., 2002;
Wang et al., 2004). Commercially obtained antibodies were:
rabbit anti-AIF monoclonal antibody (Epitomics; Epi), mouse
anti-AIF monoclonal antibody (E-1), anti-ANT (adenine
nucleotide translocator), anti-Tom20 (translocase of outer
membrane 20) and anti-Tim23 (translocase of inner membrane
23) (all from Santa Cruz Biotechnology), anti-VDAC (voltage-
dependent anion channel) (Calbiochem), anti-Smac (second
mitochondrial-derived activator of caspase; Chemicon) and
anti-cyt c (BD Pharmingen).
Submitochondrial fractionation
Mitochondria prepared from rat brains were resuspended in
3.5 ml of isotonic buffer, transferred to the French press and
a pressure of 16000 psi (1 psi56.9 kPa) was applied.
Mitochondria were homogenized with a flow valve rate of
15 drops/min. Lysate was centrifuged at 12000 g for 10 min
and the pellet was saved as the mitoplast fraction. The
supernatant was subjected to ultracentrifugation at 59000
rev./min (TLA-120.2 rotor) for 1 h and further fractionated
into the intermembrane space and outer membrane fractions
respectively. Equal amounts of protein from each fraction
were loaded for immunoblot analysis.
Electron microscopy
Mice were perfused through the heart with 4% formaldehyde
and 0.1% glutaraldehyde in phosphate buffer. Mouse
neocortices were cut into 0.5–1 mm slices, cryoprotected,
quick-frozen in liquid propane (2170˚C), and subjected to
freeze substitution. Specimens were embedded in methacry-
late resin (Lowicryl HM20) and polymerized by UV light below
0˚C. Ultrathin sections were incubated with rabbit mono-
clonal antibodies against AIF (10 mg/ml; Epi) followed by goat
anti-rabbit antibody coupled to 15 nm Colloidal Gold.
The sections were examined in a Philips CM 10 electron
microscope at 60 kV.
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preparation and cytotoxicity
Primary neuronal cultures from cortex were prepared as
described previously (Dawson et al., 1993). At 2 h after NMDA
(Sigma) treatment (500 mM for 5 min), cells were harvested.
Nuclear subcellular fractions and post-nuclear subcellular
fractions, which includes mitochondria and cytosol, were
prepared (Wang et al., 2004). PARP-1-dependent cell death
was induced by 500 mM NMDA for 5 min. Viability was
assessed 24 h after treatment with Hoechst 33342 (7 mM; for
total nuclei) and propidium iodide (2 mM; for dead cell nuclei)
double staining.
Quantification and statistical analysis
Immunogold labelling was quantified with analySIS (Soft
Imaging Systems) from digital images of two sections from
two mouse neocortices (50 mitochondria from each section)
acquired in a blinded manner. Mitochondrial labelling was
recorded as the number of gold particles per unit area and
determined by an extension of analySIS. ROIs (regions of
interest) were drawn interactively, and ROI results determined
semi-automatically and transferred to SPSS version 13.
Significance was determined using a Student’s unpaired
t test; P,0.05 was considered statistically significant. Data
are the means¡S.E.M.
RESULTS
Sub-mitochondrial localization of AIF
AIF has been reported in the intermembrane space of
mitochondria (Susin et al., 1999). Previously we have
observed that AIF release occurs before that of cyt c and
caspase activation after DNA damage and NMDA excitotoxi-
city (Yu et al., 2002; Wang et al., 2004). Since AIF is a much
larger protein than cyt c, the relative kinetics of AIF
translocation to the nucleus compared with cyt c release
from mitochondria was puzzling. To address this issue, the
localization of AIF was examined at submitochondrial levels
in rodent brain. Three different AIF antibodies were used
JH532 (Wang et al., 2004), an rabbit anti-AIF monoclonal
antibody (Epi) and a mouse anti-AIF monoclonal antibody (E-
1). To confirm the specificity of these antibodies, mitochon-
dria were prepared from WT (wild-type) or Hq (Harlequin)
mice, which have substantially reduced levels of AIF due to a
proviral insertion (Klein et al., 2002). All three antibodies
recognized only one band of the same molecular mass (62
kDa) on immunoblot, with decreased intensity in Hq samples
(Figure 1A). A Percoll gradient was used to obtain intact
mitochondria for in vitro studies. For the alkaline treatment,
purified mitochondria were incubated with 0.1 M Na2CO3 (pH
11.5). In this experiment, VDAC and Tom20, which are integral
mitochondrial membrane proteins, served as markers and
were retained in the membrane fraction. In contrast, AIF was
found in the soluble supernatant along with the soluble
mitochondrial proteins, Smac and cyt c (Figure 1B), suggest-
ing that AIF is not an integral membrane protein. For salting-
out experiments, mitochondria were incubated in buffers
containing different concentrations of NaCl. After pelleting
mitochondria by centrifugation, the supernatants were
probed with anti-AIF antibodies (Figure 1C). Increasing
concentrations of NaCl led to dissociation of AIF from
mitochondria (Figure 1C). In contrast, Smac and MnSOD,
which are mitochondrial intermembrane space and matrix
proteins respectively, were not detected in the supernatant
over the concentration range of NaCl, with barely detected
levels at high-salt concentrations. These results suggest that
high-salt treatment does not alter mitochondrial integrity
and that there is a pool of AIF that is loosely associated with
the outer membrane of mitochondria on the cytosolic side.
Purified mitochondria were treated with proteinase K to
degrade exposed proteins (Figure 2A). Much of Tom20 faces
the cytosol, anchored by an N-terminal transmembrane
segment. Tom20 is highly sensitive to proteinase K, whereas
the intermembrane space protein, Smac, is protected by the
outer membrane and is insensitive to proteinase K
(Figure 2A). Notably, AIF is moderately sensitive to proteinase
K with 72.6¡4.5% (mean for five independent experiments)
of AIF remaining following treatment, suggesting that a small
Figure 1 Biochemical determination of AIF localization in brain
mitochondria
(A) Immunoblot of mitochondrial fractions (5 mg each) from WT and Hq mice
brains probed with anti-AIF antibodies: JH532, Epi and E-1. The molecular
mass in kDa is indicated on the left-hand side. COX IV, cyt c oxidase subunit
IV. (B) The insoluble pellet (P) and soluble supernatant (S) of an alkaline
extraction of brain mitochondria extraction probed for AIF, the membrane
proteins VDAC and Tom20, and the soluble proteins Smac and cyt c. T, total
mitochondria. (C) Salting-out experiment. AIF is washed out with the
increasing concentrations of NaCl, whereas MnSOD and Smac remain in the
pellet. M (in lane 6), total mitochondria.
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277pool of AIF resides at the outer mitochondrial membrane
(Figure 2A). All proteins are degraded by proteinase K after
disruption of mitochondria by sonication (Figure 2B), indi-
cating that the difference in their sensitivity to proteinase K
is not due to their ability to be proteolytically degraded, but
due to their differential localization. Taken together, these
results suggest that a pool of AIF is associated with the cyto-
solic surface of the outer membrane in brain mitochondria.
To further examine the localization of AIF, submitochon-
drial fractionations were obtained using a French press. VDAC
and ANT are the core components of the mitochondrial
permeability transition pore complex at the outer and inner
membranes respectively (Lemasters et al., 1998; Crompton,
1999). Tom20 and Tim23 are part of the mitochondrial
protein transport machinery at the outer and inner
membranes respectively (Mokranjac and Neupert, 2005).
Smac and cyt c are pro-apoptotic proteins located within
the intermembrane space. The French press generates a
physical shearing force to skin mitochondria of the outer
membrane without disrupting membrane integrity which
occurs during osmotic swelling or detergent treatments
(Hoppel et al., 1998). Under these conditions, AIF is found in
both outer membrane and inner membrane fractions
(Figure 3). However, the intermembrane space is the least
likely localization for AIF. This suggests that, in accordance
with other reports (Arnoult et al., 2002), AIF is associated with
the inner membrane rather than soluble in the intermem-
brane space. To judge the efficacy of separation, the fractions
were subjected to immunoblot analyses with antibodies
against the marker proteins. The marker proteins were highly
enriched at the expected fractions, demonstrating efficient
and clean separation of outer membrane, intermembrane
space and inner membrane fractions (Figure 3).
Electron microscopic localization of AIF
To confirm the results of the biochemical studies, we used
post-embedding electron microscopy with a rabbit anti-AIF
monoclonal antibody. Analysis of ultrathin sections of WT and
Hq mice brains give similar results as the biochemical
approaches, revealing reproducible association of gold
particles with the outer, as well as the inner, mitochondrial
membrane in WT mice (Figure 4). Counting particles in the
corridor between 0 and 30 mm of the outer membrane
Figure 2 AIF is localized, in part, to the outer mitochondrial membrane
(A) Brain mitochondria (400 mg) were treated with proteinase K (1 mg) and
immunoblotted to detect AIF, Tom20 and Smac. Tom20 and Smac are
resistant to protease K. (B) Disruption of mitochondrial structure by brief
sonication renders all proteins sensitive to proteinase K. Experiments were
repeated three times with similar results.
Figure 3 Submitochondrial fractionation
Mitochondria (T) isolated from the rat brain were further separated into the
outer membrane fraction (OM), intermembrane space fraction (IMS) and
mitopast (Mp; inner membrane and matrix) using a French press. For
immunoblot analysis, 5 mg of protein from each fraction was probed for AIF,
VDAC and Tom20 (outer membrane), Smac and cyt c (intermembrane space),
and ANT and Tim20 (inner membrane) respectively. Experiments were
repeated three times with similar results.
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with the outer membrane. The Hq mouse brain shows very
few immunogold particles (Figure 4). The number of gold
particles per mitochondria was quantified for WT (4.2¡0.97
gold particles/mitochondria) and for Hq (0.08¡0.07 gold
particles/mitochondria) mice (n550 for each) providing
evidence for specificity and selectivity of the antibody used
in these experiments.
Excitotoxic releasable pool of AIF in cortical
neurons
To explore whether the outer membrane pool of AIF is released
during glutamate excitotoxicity, cultured primary cortical
neurons were exposed to a neurotoxic concentration of 500
mM NMDA. Immunoblot analysis of nuclear fractions and
postnuclear fractions, which includes cytoplasm and mitochon-
drial proteins, revealedtranslocationof approx. 20% ofthe total
AIF to the nucleus as the uncleaved form (Figures 5A and 5B),
which is consistent with the estimation of the outer membrane
AIF pool by the various protein biochemical approaches and
electron microscopy. Moreover, NMDA treatment at 500 mMf o r
5 minwassufficienttocause cell death(Figure 5C),which could
be prevented by the PARP inhibitor DPQ (Figure 5C) or genetic
knockout of PARP-1 via blocking AIF release from the
mitochondria (Yu et al., 2002; Wang et al., 2009b).
DISCUSSION
In parthanatos, AIF is quickly released from mitochondria.
Our data from the alkaline extraction assay, high-salt
concentration treatment, protease treatment, submitochon-
drial fractionation and electron microscopy demonstrate that
a fraction of AIF is attached to the outer membrane surface
of brain mitochondria. This localization of AIF may allow the
rapid release of AIF prior to the later release of integral
mitochondrial proteins in parthanatos. The immunogold
particles labelling AIF are exclusively located to the
mitochondria. Although the predominant immunogold signal
is at the inner membrane, particles are consistently observed
at the outer membrane. Gold particles associated with the
outer aspect of the outer membrane are separated by more
than 25 nm from the inner mitochondrial membrane. These
particles cannot be attributed to epitopes in the inner
membrane, as ,25 nm corresponds to the maximum distance
between a 15 nm gold particle and the respective epitope
(Matsubara et al., 1996). Because of high protein content,
specificity of immunogold labelling of mitochondria should
always be assessed with extreme care. In the present study,
the Hq mice with 80% down-regulation of AIF expression
(Klein et al., 2002) are an invaluable tool to verify the
Figure 4 AIF immunogold labelling in mouse neocortex
Ultrathin Lowicryl sections from WT (A–C)o rH q( D) mouse neocortex were subjected to immunogold cytochemistry. Most of the gold
particles are detectedoverinnermembranes ofmitochondria(indicatedby *), but some mitochondriashowgold particles associatedwith
the outer membrane (indicated by {) in WT mice. Particles are rarely found in mitochondria of Hq mice.
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279selectivity of the anti-AIF antibodies. The immunolabelling is
corroborated by an almost complete loss of mitochondrial
labelling in the Hq mice neocortex. Thus the immunogold
results support the concept that AIF is associated with both
the inner membrane and outer membrane, which is partly
consistent with previous studies reporting AIF association
with the inner mitochondrial membrane and intermembrane
space (Arnoult et al., 2002).
The potential topology of AIF using tagged AIF peptides
showed that mature AIF is an integral inner membrane
protein with its N-terminal portion in the matrix and the bulk
of the C-terminus in the inner membrane space (Otera et al.,
2005). However, the GFP (green fluorescent protein)-tagged
AIF carrying an extra 27 kDa peptide and forced over-
expression of AIF or AIF peptide fragments may localize and
behave differently from endogenous protein (Otera et al.,
2005). The advantage and contribution of the present report
is studying the localization of endogenous AIF using extensive
biochemical approaches in combination with morphometric
analysis in rodent brain tissues. Notably, AIF is proposed as an
integral inner membrane protein after alkaline treatment at
pH 10.5 (Otera et al., 2005), rather than pH 11.5, although pH
11.5 is the typical protocol for sodium carbonate treatment
to distinguish between integral and peripheral membrane
proteins (Fujiki et al., 1982). Peripheral membrane proteins
are readily stripped by sodium carbonate treatment, whereas
integral membrane proteins are solubilized only by the
conditions disrupting the lipid bilayer. At pH 11.5, we recover
AIF in the supernatant fraction.
Although the mechanisms by which the outer mitochon-
drial membrane is permeabilized remain contentious, the
outer membrane has been regarded as the barrier containing
dangerous pro-apoptotic proteins in the intermembrane
space of mitochondria. The outer membrane theoretically
needs to be broken or permeabilized for the release of pro-
apoptotic molecules to activate downstream cell-death
cascades. However, localization of AIF on the cytosolic
surface of mitochondria would not require membrane
permeabilization and may require other mechanisms for its
release. Consistent with this notion, we observed that in the
first phase of parthanatos approx. 14–20% of AIF is released
from mitochondria in the first 2 h as the 62 kDa uncleaved
form in the present study, as well as previous studies (Andrabi
et al., 2006; Yu et al., 2006; Wang et al., 2009b).
The results of the present study clearly show that AIF is
localized in two different compartments of brain mitochondria.
Approx.70%ofAIFresidesinthemitochondrialintermembrane
space, and 30% of AIF associates with the mitochondrial outer
membrane, which has not been reported previously, thus
adding new insights into AIF function. There is precedence for
integral mitochondrial proteins to exhibit localization to the
mitochondrial outer membrane. For instance, yeast fumarase
undergoes retrograde movement after mitochondrial import to
reside, in part, on the mitochondrial outer membrane (Knox et
al., 1998). Thus the biological mechanism of AIF localization on
the mitochondrial outer membrane might involve a similar
retrograde movement of the partially processed AIF back
through the translocation pore (Knox et al., 1998). Alternatively
NADH:cytochrome b5 reductase exists in two different
submitochondrial compartments via incomplete arrest in the
outer membrane (Hahne et al., 1994). The arrest of a portion of
the AIF precursor protein on the mitochondrial outer mem-
brane where it is processed to mature AIF by interacting with
mitochondrial protein import machinery may account for the
outer mitochondrial membrane localization (Hahne et al.,
1994). Further investigation is required to reveal the mech-
anism for the dual localization of AIF.
In summary, in the present study we find that there is a
small, but significant, fraction of AIF associated with the
outer mitochondrial membrane on the cytosolic side. Multiple
biochemical approaches and ultrastructural analysis by
electron microscopy detect endogenous AIF associated with
the inner and outer membrane of mitochondria in the brain
tissues. Dual localization of AIF may shed light into
understanding the release mechanisms in parthanatos.
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